Imaging of HER-2 overexpression in tumors for guiding therapy.
about
Disruption of CTCF at the miR-125b1 locus in gynecological cancersMolecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agentsInfluence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules: comparison with (111)In-labeled counterpartsMolecular imaging: 18F-FDG PET and a whole lot more.'Image and treat': an individualized approach to urological tumorsPhage display and molecular imaging: expanding fields of vision in living subjects.In vivo targeting of HER2-positive tumor using 2-helix affibody molecules.In Vitro and In Vivo Pre-Clinical Analysis of a F(ab')(2) Fragment of Panitumumab for Molecular Imaging and Therapy of HER1 Positive CancersEGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides.Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies?68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PETMolecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy.In vivo method to monitor changes in HER2 expression using near-infrared fluorescence imaging.Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT.Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer.Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications.The evolution of imaging in cancer: current state and future challenges.Nucleic acid and peptide aptamers: fundamentals and bioanalytical aspects.An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers.Polymersomes and their applications in cancer delivery and therapy.Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3:08699 affibody molecule.Human Epidermal Growth Factor Receptor 2-Targeted PET/Single- Photon Emission Computed Tomography Imaging of Breast Cancer: Noninvasive Measurement of a Biomarker Integral to Tumor Treatment and Prognosis.Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts.Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [(111)In]-labeled CHX-A″DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines.Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer.Engineering and functionalization of the disulfide-constrained miniprotein min-23 as a scaffold for diagnostic application.Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m.Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe.Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction: Chemistry and preliminary evaluation.A near-infrared multifunctional fluorescent probe with an inherent tumor-targeting property for bioimaging.Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome.HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization.Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of 99mTc-labeled recombinant Affibody molecules.Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors.Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast CancerBiochemie 2009
P2860
Q21261278-64FA1894-1682-4057-8D4B-717C9082CF4EQ28304646-46EA376D-4CB3-446B-974C-5DFD71FB4980Q28535054-4A35EFB2-9820-41BA-BE2C-C83FB4134CBDQ30482989-8B43A7BB-AC04-446C-AFFC-D118E73744E2Q33792596-E1FD1809-2A51-405F-87C3-26B0CB938182Q33849788-BB28F735-46AD-4D0F-9A0E-1ED6E8FD4F69Q34231627-4C7DD147-903E-4393-89F4-E4860027BB9CQ35162293-B557C1C6-C5B0-484C-B644-89B8BC938107Q35184816-569CCF6D-AB70-41A4-9E03-F210A7F99090Q35879814-61B6F1D4-BAAB-4380-9BEE-FE1C5A4DA70AQ36085489-DAF5CD4D-2A60-42E4-AC4C-14D20FE3D162Q36105964-4E0338E0-4240-4DAE-B756-0C8B64EE4DE8Q36357046-2C907785-D410-4056-B0E3-882EF36606C8Q36510875-2CFEA661-CE47-4903-9484-9D39637F2962Q37457888-9F8C37F8-126F-4874-A679-C741FC699736Q37730252-C642E7DD-B924-4114-8FF3-69FA5FB986B4Q37848518-6CE344BB-6DF3-4A17-9536-89EE855171E8Q37972851-7C47AE69-F0D9-4731-A05F-0AAD948E6C5AQ38312110-84F4C2AF-D6B7-463E-BF1E-4E002A787EF6Q38578305-56C00D51-3F9E-491C-BDE5-94857B49AD26Q39016180-5260BF6C-2061-4A14-8826-BB8F0B783108Q39346715-D1B978B4-28DF-42DB-87D0-CF7985E1ECD3Q39376122-C30AC805-82D1-491D-A2F4-29ABA6EBF6BEQ39398599-23B94FBA-6DFF-41E6-A901-A37F48E0149BQ42018419-38A94B4A-8FCE-48B9-BA75-F6E251574E00Q42070603-93B9DF71-AEE0-4182-9E33-34F2C5D9EE13Q45107054-6E1E0D23-8BE4-4FA8-BAB3-EA99CC4F751DQ46219345-954CBE9D-D549-46E4-8FCD-8F0D10DCF0F3Q50326884-25512163-367D-4816-A32C-228D382D10BCQ52657511-98E53AE7-8363-4DCD-AB45-762981C303BFQ53200172-44E5DAA0-BE83-469F-8CEA-4D7F6E13636FQ54399364-305ACC10-535B-4605-9981-5A8F3983DDEFQ54594744-5368F217-1A22-4A7A-B25E-6A9F5E7E4A00Q55054249-B51C9FD3-1E48-4169-B19D-52CBAEB728BEQ55425539-2620650E-DC12-4AC3-88D9-367D3B2202BCQ57110662-FD25445B-795C-4E10-8945-129466045E5FQ57260233-6A15D053-CE03-4701-BC7E-CBDFC60F474D
P2860
Imaging of HER-2 overexpression in tumors for guiding therapy.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Imaging of HER-2 overexpression in tumors for guiding therapy.
@ast
Imaging of HER-2 overexpression in tumors for guiding therapy.
@en
Imaging of HER-2 overexpression in tumors for guiding therapy.
@nl
type
label
Imaging of HER-2 overexpression in tumors for guiding therapy.
@ast
Imaging of HER-2 overexpression in tumors for guiding therapy.
@en
Imaging of HER-2 overexpression in tumors for guiding therapy.
@nl
prefLabel
Imaging of HER-2 overexpression in tumors for guiding therapy.
@ast
Imaging of HER-2 overexpression in tumors for guiding therapy.
@en
Imaging of HER-2 overexpression in tumors for guiding therapy.
@nl
P1476
Imaging of HER-2 overexpression in tumors for guiding therapy.
@en
P2093
Tolmachev V
P304
P356
10.2174/138161208786404290
P577
2008-01-01T00:00:00Z